A study of brensocatib in patients with bronchiectasis
Latest Information Update: 15 Oct 2024
Price :
$35 *
At a glance
- Drugs Brensocatib (Primary)
- Indications Bronchiectasis
- Focus Therapeutic Use
- 15 Oct 2024 New trial record
- 08 Oct 2024 According to Insmed media release, the company plans to file a New Drug Application with the U.S. Food and Drug Administration for brensocatib in patients with bronchiectasis in the fourth quarter of 2024.
- 08 Oct 2024 According to Insmed media release, pending regulatory approvals, the company anticipates a launch for brensocatib in Japan in the first half of 2026.